GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veri Medtech Holdings Inc (OTCPK:VRHI) » Definitions » Interest Expense

VRHI (Veri Medtech Holdings) Interest Expense : $ Mil (TTM As of Dec. 2021)


View and export this data going back to . Start your Free Trial

What is Veri Medtech Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Veri Medtech Holdings's interest expense for the six months ended in Dec. 2021 was $ 0.00 Mil. Veri Medtech Holdings does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2021.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Veri Medtech Holdings's Operating Income for the six months ended in Dec. 2021 was $ -0.03 Mil. Veri Medtech Holdings's Interest Expense for the six months ended in Dec. 2021 was $ 0.00 Mil. Veri Medtech Holdings has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


Veri Medtech Holdings Interest Expense Historical Data

The historical data trend for Veri Medtech Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veri Medtech Holdings Interest Expense Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Interest Expense
-

Veri Medtech Holdings Semi-Annual Data
Dec21
Interest Expense -

Veri Medtech Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Veri Medtech Holdings  (OTCPK:VRHI) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Veri Medtech Holdings's Interest Expense for the six months ended in Dec. 2021 was $0.00 Mil. Its Operating Income for the six months ended in Dec. 2021 was $-0.03 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2021 was $0.00 Mil.

Veri Medtech Holdings's Interest Coverage for the quarter that ended in Dec. 2021 is calculated as

Veri Medtech Holdings had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Veri Medtech Holdings Business Description

Traded in Other Exchanges
N/A
Address
1660 International Dr, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.

Veri Medtech Holdings Headlines